These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17048473)

  • 21. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
    Balthasar S; Michaelis K; Dinauer N; von Briesen H; Kreuter J; Langer K
    Biomaterials; 2005 May; 26(15):2723-32. PubMed ID: 15585276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering precision nanoparticles for drug delivery.
    Mitchell MJ; Billingsley MM; Haley RM; Wechsler ME; Peppas NA; Langer R
    Nat Rev Drug Discov; 2021 Feb; 20(2):101-124. PubMed ID: 33277608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells?
    Cong VT; Houng JL; Kavallaris M; Chen X; Tilley RD; Gooding JJ
    Chem Soc Rev; 2022 Aug; 51(17):7531-7559. PubMed ID: 35938511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery.
    Bergen JM; von Recum HA; Goodman TT; Massey AP; Pun SH
    Macromol Biosci; 2006 Jul; 6(7):506-16. PubMed ID: 16921538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of silica-coated nanoparticles by HeLa cells.
    Xing X; He X; Peng J; Wang K; Tan W
    J Nanosci Nanotechnol; 2005 Oct; 5(10):1688-93. PubMed ID: 16245529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
    Nam HY; Kwon SM; Chung H; Lee SY; Kwon SH; Jeon H; Kim Y; Park JH; Kim J; Her S; Oh YK; Kwon IC; Kim K; Jeong SY
    J Control Release; 2009 May; 135(3):259-67. PubMed ID: 19331853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
    Moritz M; Geszke-Moritz M
    Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioactive coatings based on polyelectrolyte multilayer architectures functionalized by embedded proteins, peptides or drugs.
    Leguen E; Chassepot A; Decher G; Schaaf P; Voegel JC; Jessel N
    Biomol Eng; 2007 Feb; 24(1):33-41. PubMed ID: 16860599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-formulations of drugs: Recent developments, impact and challenges.
    Jeevanandam J; Chan YS; Danquah MK
    Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical Formulation Methods for Improving Retinal Drug Delivery.
    Stryjewski TP; Stefater JA; Eliott D
    Semin Ophthalmol; 2019; 34(4):218-222. PubMed ID: 31146619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells.
    Evangelatov A; Skrobanska R; Mladenov N; Petkova M; Yordanov G; Pankov R
    Drug Deliv; 2016 Sep; 23(7):2235-2244. PubMed ID: 25268149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
    Elzoghby AO
    J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bio-inspired chimeric drug delivery nano systems (Chi-DDnSs): their fractal hologram and regulatory aspects.
    Pippa N; Pispas S; Demetzos C
    Adv Exp Med Biol; 2015; 822():199-200. PubMed ID: 25416991
    [No Abstract]   [Full Text] [Related]  

  • 37. Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery.
    Partlow KC; Lanza GM; Wickline SA
    Biomaterials; 2008 Aug; 29(23):3367-75. PubMed ID: 18485474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEG - a versatile conjugating ligand for drugs and drug delivery systems.
    Kolate A; Baradia D; Patil S; Vhora I; Kore G; Misra A
    J Control Release; 2014 Oct; 192():67-81. PubMed ID: 24997275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):595-606. PubMed ID: 17970663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.